On Wednesday, U.S. Senator Rand Paul (R-KY) sent a letter to Acting Director of the National Institutes of Health, Lawrence A. Tabak regarding the National Institutes of Health (NIH)’s processing of Freedom of Information Act (FOIA) requests related to the origins of COVID-19. The letter is in response to recent revelations that the NIH is withholding information from the public for political reasons.
“Unfortunately, NIH has repeatedly disregarded its responsibilities under FOIA and the American people’s right to agency records. For almost two years, public interest groups and media organizations have been forced to engage in protracted litigation to obtain documents related to NIH’s involvement in COVID-19. The records NIH has produced have been heavily redacted,” Dr. Paul wrote. “Of particular concern is NIH’ s recent admission in Court that the agency is withholding portions of emails between employees because they ‘could be used out of context and serve to amplify the already prevalent misinformation regarding the origins of the coronavirus pandemic.’ This suggests NIH is censoring the information it releases to the public about the origins of the pandemic.”
Dr. Paul requested the following information in response to his letter:
- A detailed index of all information withheld pursuant to a FOIA request, either in part or in whole, because such information “could be used out of context and serve to amplify the already prevalent misinformation regarding the origins of the coronavirus pandemic.”
- A detailed description of the process by which the agency determines what information “could be used out of context and serve to amplify the already prevalent misinformation regarding the origins of the coronavirus pandemic”, including all individuals involved in making such determination.
- A list of all changes since January 2020 to NIH’s FOIA review and/or approval process for agency and/or agency component records, including, but not limited to, temporary and informal policies.
- A list of all instances since January 2020 where the NIH Director, Acting Director, and/or head of an agency component was involved in reviewing/clearing a FOIA response before release to the requestor.
- A list of all instances since January 2020 where the NIH Director, Acting Director, and/or head of an agency component participated in any matter related to a FOIA request for records in which they were directly or indirectly personally involved.
- A description of what role, if any, the NIH Director, Acting Director, and head of an agency component has in the FOIA process, including, but not limited to, any authority for such individuals to withhold information from production under a valid FOIA request.
You can read Dr. Paul’s full letter to Acting Director Tabak HERE.
